Extended Data Fig. 9: Association of survival with signature T cell lineage genes in the INSPIRE Trial.
From: A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer

Overall survival of patients with advanced solid cancers (mixed histologies) treated with pembrolizumab in the INSPIRE trial. Survival split on median TRDC, TRDV2, CD4 and CD8B expression in primary tumour prior to pembrolizumab. Plotted in months after third cycle of pembrolizumab. Gehan-Breslow-Wilcoxon test. Significant p values shown. n.s. not significant.